- Acute Myeloid Leukemia (AML)
- Bladder Cancer
- Breast Cancer
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Colon Cancer
- Endometrial Cancer
- Esophageal Cancer
- Heart Failure
- Hypertrophic Cardiomyopathy (HCM)
- Liver Cancer
- Lung Cancer
- Melanoma
- Multiple Myeloma
Multiple Myeloma
Discover local Multiple Myeloma resources:
- Multiple Sclerosis (MS)
- Myelodysplastic Syndrome (MDS)
- Myeloproliferative Neoplasms
- Non-Hodgkin Lymphoma
- Ovarian Cancer
Ovarian Cancer
Discover local Ovarian Cancer resources:
- Prostate Cancer
- Psoriasis
- Diseases
- Acute Myeloid Leukemia (AML)
- Bladder Cancer
- Breast Cancer
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Colon Cancer
- Endometrial Cancer
- Esophageal Cancer
- Liver Cancer
- Lung Cancer
- Melanoma
- Multiple Myeloma
Multiple Myeloma: Main Page
- Myelodysplastic Syndrome (MDS)
- Myeloproliferative Neoplasms
- Ovarian Cancer
Ovarian Cancer: Main Page
View Ovarian Cancer Main PageDiscover Local Ovarian Cancer resources:
- Non-Hodgkin Lymphoma
- Prostate Cancer
- Cold Agglutinin Disease (CAD)
- Heart Failure
- Hypertrophic Cardiomyopathy (HCM)
- Mental Health
- Multiple Sclerosis (MS)
- Psoriasis
- Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- Von Hippel-Lindau Disease
- Close the Gap
- SurvivorNetTV
- Clinical Trials
- News
- About Us
- Newsletters and Guides
- SN Connect
- Contact Us
- Studios
- Sign Up
- Log In
Dr. Eytan Stein
Chief of the Leukemia Service
Memorial Sloan Kettering Cancer Center
Dr. Eytan Stein, Chief of the Leukemia Service at Memorial Sloan Kettering Cancer Center, is an hematologist-oncologist at who specializes in caring for people with acute and chronic leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms. Dr. Stein is also an active clinical researcher who develops new and innovative approaches to treating acute myeloid leukemia (AML). Dr. Stein is the principal investigator on a wide variety of clinical trials for people with AML working to develop new therapies — such as small molecule inhibitors — that can more precisely and effectively target AML.
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.
Sign Up for SN+
Sign up now for access to powerful tools, top experts, and customized information to help you fight cancer.
- Personalized content tailored to your profile and disease type
- Access exclusive patient guides
- Breaking treatment information and expert perspectives
- and more...
Already have an account? Sign In